![Kathleen Gogas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kathleen Gogas
Plus aucun poste en cours
Historique de carrière de Kathleen Gogas
Anciens postes connus de Kathleen Gogas
Sociétés | Poste | Début | Fin |
---|---|---|---|
Symic Bio, Inc.
![]() Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 21/04/2016 | - |
Formation de Kathleen Gogas
Albany Medical College | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Symic Bio, Inc.
![]() Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Kathleen Gogas
- Expérience